Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility
The H5N1 influenza A viruses have circulated widely in the avian population for 10 years with only sporadic infection of humans observed and no sustained human to human transmission. Vaccination against potential pandemic strains is one strategy in planning for future influenza pandemics; however, the success of live attenuated vaccines for H5N1 has been limited, due to poor replication in the human upper respiratory tract (URT). Mutations that increase the ability of H5N1 viruses to replicate in the URT will aid immunogenicity of these vaccines and provide information about humanizing adaptations in H5N1 strains that may signal transmissibility. As well as mediating receptor interactions, the haemagglutinin (HA) protein of influenza facilitates fusion of the viral membrane and genome entry into the host cell; this process is pH dependent. We have shown in this study that the pH at which a panel of avian influenza HA proteins, including H5, mediate fusion is higher than that for human influenza HA proteins, and that mutations in the H5 HA can reduce the pH of fusion. Coupled with receptor switching mutations, increasing the pH stability of the H5 HA resulted in increased viral shedding of H5N1 from the nasal cavity of ferrets and contact transmission to a co-housed animal. Ferret serum antibodies induced by infection with any of the mutated H5 HA viruses neutralized HA pseudotyped lentiviruses bearing homologous or heterologous H5 HAs, suggesting that this strategy to increase nasal replication of a vaccine virus would not compromise vaccine efficacy.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
AlberiniI., Del TordelloE., FasoloA., TempertonN. J., GalliG., GentileC., MontomoliE., HilbertA. K., BanzhoffA.other authors2009; Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses. Vaccine 27:5998–6003 [View Article][PubMed]
Ayora-TalaveraG., SheltonH., ScullM. A., RenJ., JonesI. M., PicklesR. J., BarclayW. S.2009; Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS ONE 4:e7836 [View Article][PubMed]
BenderC., HallH., HuangJ., KlimovA., CoxN., HayA., GregoryV., CameronK., LimW., SubbaraoK.1999; Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254:115–123 [View Article][PubMed]
BeyerW. E. P., RuigrokR. W. H., van DrielH., MasurelN.1986; Influenza virus strains with a fusion threshold of pH 5.5 or lower are inhibited by amantadine. Arch Virol 90:173–181 [View Article][PubMed]
CarratF., LuongJ., LaoH., SalléA. V., LajaunieC., WackernagelH.2006; A ‘small-world-like’ model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 4:26 [View Article][PubMed]
CauchemezS., BhattaraiA., MarchbanksT. L., FaganR. P., OstroffS., FergusonN. M., SwerdlowD., SodhaS. V., MollM. E.other authors2011; Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci U S A 108:2825–2830 [View Article][PubMed]
ChenZ., ZhouH., KimL., JinH.2012b; The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets. J Virol 86:2780–2786 [View Article][PubMed]
ChutinimitkulS., van RielD., MunsterV. J., van den BrandJ. M., RimmelzwaanG. F., KuikenT., OsterhausA. D., FouchierR. A., de WitE.2010; In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 84:6825–6833 [View Article][PubMed]
EllemanC. J., BarclayW. S.2004; The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321:144–153 [View Article][PubMed]
GaoY., ZhangY., ShinyaK., DengG., JiangY., LiZ., GuanY., TianG., LiY.other authors2009; Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5:e1000709 [View Article][PubMed]
GiannecchiniS., CampitelliL., CalzolettiL., De MarcoM. A., AzziA., DonatelliI.2006; Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. J Gen Virol 87:171–175 [View Article][PubMed]
HarveyR., MartinA. C., ZambonM., BarclayW. S.2004; Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. J Virol 78:502–507 [View Article][PubMed]
HattaM., GaoP., HalfmannP., KawaokaY.2001; Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840–1842 [View Article][PubMed]
KrennB. M., EgorovA., Romanovskaya-RomankoE., WolschekM., NakowitschS., RuthsatzT., KiefmannB., MorokuttiA., HumerJ.other authors2011; Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS ONE 6:e18577 [View Article][PubMed]
LinY. P., WhartonS. A., MartínJ., SkehelJ. J., WileyD. C., SteinhauerD. A.1997; Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 233:402–410 [View Article][PubMed]
LoebM., RussellM. L., MossL., FonsecaK., FoxJ., EarnD. J., AokiF., HorsmanG., Van CaeseeleP.other authors2010; Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA (J Am Med Assoc) 303:943–950 [View Article][PubMed]
MainesT. R., ChenL. M., Van HoevenN., TumpeyT. M., BlixtO., BelserJ. A., GustinK. M., PearceM. B., PappasC.other authors2011; Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413:139–147 [View Article][PubMed]
NeumannG., KawaokaY.1999; Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. Adv Virus Res 53:265–300 [View Article][PubMed]
ReedM. L., YenH. L., DuBoisR. M., BridgesO. A., SalomonR., WebsterR. G., RussellC. J.2009; Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol 83:3568–3580 [View Article][PubMed]
ReedM. L., BridgesO. A., SeilerP., KimJ. K., YenH. L., SalomonR., GovorkovaE. A., WebsterR. G., RussellC. J.2010; The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84:1527–1535 [View Article][PubMed]
RobertsK. L., SheltonH., ScullM., PicklesR., BarclayW. S.2011; Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo. J Gen Virol 92:1822–1831 [View Article][PubMed]
StevensJ., CorperA. L., BaslerC. F., TaubenbergerJ. K., PaleseP., WilsonI. A.2004; Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866–1870 [View Article][PubMed]
StevensJ., BlixtO., TumpeyT. M., TaubenbergerJ. K., PaulsonJ. C., WilsonI. A.2006; Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404–410 [View Article][PubMed]
SuY., YangH. Y., ZhangB. J., JiaH. L., TienP.2008; Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells. Arch Virol 153:2253–2261 [View Article][PubMed]
WangW., LuB., ZhouH., SuguitanA. L.Jr, ChengX., SubbaraoK., KembleG., JinH.2010; Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J Virol 84:6570–6577 [View Article][PubMed]
WashingtonN., SteeleR. J., JacksonS. J., BushD., MasonJ., GillD. A., PittK., RawlinsD. A.2000; Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm 198:139–146 [View Article][PubMed]
WHO (2012a Antigenic and Genetic Characteristics of Zoonotic Influenza Viruses and the Development of Candidate Vaccines for Pandemic Prepardness. Geneva: World Health Organization
WHO (2012b Cumulative Number of Confirmed Human Cases for Avian Influenza A (H5N1) Reported to WHO, 2003–2012. Geneva: World Health Organization
YamadaS., SuzukiY., SuzukiT., LeM. Q., NidomC. A., Sakai-TagawaY., MuramotoY., ItoM., KisoM.other authors2006; Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378–382 [View Article][PubMed]
Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility